China Pharma Holdings, Inc.
CPHI- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001106644
No open-market purchases or sales by China Pharma Holdings, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $134.5K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $134.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CPHI, Q2 2026
No superinvestor reported holding CPHI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by China Pharma Holdings, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by China Pharma Holdings, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in China Pharma Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 125,445 | $82.8K | 0.00% | +112,521+870.6% | Added |
| Two Sigma Securities, LLC | 35,666 | $23.5K | 0.00% | +35,666 | New |
| Renaissance Technologies LLC | 15,045 | $9.93K | 0.00% | +3,627+31.8% | Added |
| Jane Street Group, LLC | 13,886 | $9.17K | 0.00% | +13,886 | New |
| Ground Swell Capital, LLC | 10,610 | $7.00K | 0.01% | +10,610 | New |
| UBS Group AG | 3,109 | $2.05K | 0.00% | +2,720+699.2% | Added |
| EFG International AG | 40 | $26 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |